Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
MS has been associated with fatigue, attention problems, and a number of cognitive difficulties. There is no treatment approved yet to treat these problems. We hypothesize that the addition of Provigil to an existing immunomodulatory agent (Avonex) will lead to improved fatigue, attention, and overall cognition in MS patients with attention problems.
Epistemonikos ID: 7bf66c06294e6cf7c69e2f24702f26b47871a234
First added on: May 04, 2024